Literature DB >> 16008546

Angiotensin converting enzyme gene, smoking and mortality in a population-based study.

A Arias-Vásquez1, F A Sayed-Tabatabaei, A F C Schut, A Hofman, A M Bertolli-Avella, J M Vergeer, Y S Aulchenko, J C M Witteman, C M van Duijn.   

Abstract

BACKGROUND: The genetic and environmental risk factors, which may influence longevity and mortality, have received much attention during more than one decade. One of the major risks for mortality is cardiovascular disease and the renin angiotensin system (RAS) plays a major role in maintaining blood pressure homeostasis. In this system, the Angiotensin Converting Enzyme (ACE) is one of the key regulators and has been studied in relation to cardiovascular disease and mortality. We aimed to evaluate if the ACE I/D polymorphism is related to total mortality in the elderly.
MATERIALS AND METHODS: Some 6968 elderly individuals from the Rotterdam study were genotyped for this polymorphism. Smoking was studied as a possible covariable or effect modifier. To examine the effect of the ACE genotype on mortality, a Cox proportional hazards model was fitted.
RESULTS: Our results show an increased risk of total mortality in subjects with age at death below 65 years carriers of the DD genotype (HR 1.8, 95% CI 1.1-2.9, P = 0.016). This association was significant in total and cause specific mortality only in those who smoke (P-value < 0.001 for gene-age interaction). Our findings suggest that the ACE gene is rather associated with early mortality than with late.
CONCLUSIONS: Individuals who carry the DD genotype appear to be susceptible to early mortality if they smoke, suggesting a possible interaction between smoking and the ACE gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008546     DOI: 10.1111/j.1365-2362.2005.01515.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity.

Authors:  Mette Soerensen; Serena Dato; Qihua Tan; Mikael Thinggaard; Rabea Kleindorp; Marian Beekman; H Eka D Suchiman; Rune Jacobsen; Matt McGue; Tinna Stevnsner; Vilhelm A Bohr; Anton J M de Craen; Rudi G J Westendorp; Stefan Schreiber; P Eline Slagboom; Almut Nebel; James W Vaupel; Kaare Christensen; Lene Christiansen
Journal:  Age (Dordr)       Date:  2012-01-12

Review 2.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

3.  Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension.

Authors:  Egidio Imbalzano; Marco Vatrano; Sebastiano Quartuccio; Rossella Di Stefano; Caterina Oriana Aragona; Federica Mamone; Angela D'Ascola; Michele Scuruchi; Francesca Felice; Giovanni Trapani; Angela Alibrandi; Vincenzo Antonio Ciconte; Roberto Ceravolo; Antonino Saitta; Giuseppe Mandraffino
Journal:  Mol Cell Biochem       Date:  2017-02-11       Impact factor: 3.396

4.  Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans.

Authors:  Matea Zajc Petranović; Tatjana Skarić-Jurić; Nina Smolej Narančić; Zeljka Tomas; Petra Krajačić; Jasna Miličić; Maja Barbalić; Spomenka Tomek-Roksandić
Journal:  Age (Dordr)       Date:  2011-05-26

5.  Hypertension and longevity: role of genetic polymorphisms in renin-angiotensin-aldosterone system and endothelial nitric oxide synthase.

Authors:  Alda Pereira da Silva; Andreia Matos; Laura Aguiar; Nuno Ramos-Marques; Ricardo Ribeiro; Ângela Gil; João Gorjão-Clara; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2018-11-20       Impact factor: 3.396

6.  Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.

Authors:  Chan Yoon; Hyun-Sik Yang; Inpyo Jeon; Yoosoo Chang; Sang Min Park
Journal:  CMAJ       Date:  2011-08-29       Impact factor: 8.262

7.  Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients.

Authors:  Alberto Pilotto; Maria G Matera; Luigi Ferrucci; Daniele Sancarlo; Gioacchino Leandro; Grazia D'Onofrio; Davide Seripa; Filomena Addante; Marilisa Franceschi; Bruno Dallapiccola
Journal:  Rejuvenation Res       Date:  2009-08       Impact factor: 4.663

Review 8.  The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19.

Authors:  George El-Arif; Antonella Farhat; Shaymaa Khazaal; Cédric Annweiler; Hervé Kovacic; Yingliang Wu; Zhijian Cao; Ziad Fajloun; Ziad Abi Khattar; Jean Marc Sabatier
Journal:  Molecules       Date:  2021-11-17       Impact factor: 4.411

9.  ACE genotype, risk and causal relationship to stroke: implications for treatment.

Authors:  Agnieszka Slowik; Tomasz Dziedzic; Joanna Pera; Dorota Wloch; Grzegorz Kopec; Andrzej Szczudlik
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.